1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 22
2.2 Major Growth Drivers 24
2.3 Market Restraints and Challenges 29
2.4 Emerging Opportunities and Market Trends 33
2.5 Porters Fiver Forces Analysis 37
3 Segmentation of Europe Market by Drug Type 41
3.1 Market Overview by Drug Type 41
3.2 Immunomodulators 43
3.3 Immunosuppressants 45
4 Segmentation of Europe Market by Drug Class 47
4.1 Market Overview by Drug Class 47
4.2 Monoclonal Antibodies 49
4.3 Interferon Beta 50
4.4 Sphingosine 1 Phosphate Receptor Modulators 51
4.5 Mixed Polymers 52
4.6 NF-?B Inhibitor 53
4.7 Pyrimidine Synthesis Inhibitor 54
4.8 Corticosteroids 55
4.9 Adrenocorticotropic Hormone 56
4.10 Other Drug Classes 57
5 Segmentation of Europe Market by Drug Category 58
5.1 Market Overview by Drug Category 58
5.2 Large-molecule Drugs 60
5.3 Small-molecule Drugs 61
6 Segmentation of Europe Market by Route of Administration 62
6.1 Market Overview by Route of Administration 62
6.2 Oral Administration 64
6.3 Parenteral Administration 65
7 Segmentation of Europe Market by MS Type 66
7.1 Market Overview by MS Type 66
7.2 Relapsing-remitting MS (RRMS) 68
7.3 Primary-progressive MS (PPMS) 69
7.4 Secondary-progressive MS (SPMS) 70
7.5 Progressive-relapsing MS (PRMS) 71
8 Segmentation of Europe Market by Distribution Channel 72
8.1 Market Overview by Distribution Channel 72
8.2 Hospital Pharmacies 74
8.3 Retail Pharmacies 75
8.4 Online Pharmacies 76
9 European Market 2020-2027 by Country 77
9.1 Overview of European Market 77
9.2 UK 80
9.3 France 82
9.4 Germany 84
9.5 Spain 86
9.6 Italy 88
9.7 Russia 90
9.8 Rest of European Market 92
10 Competitive Landscape 94
10.1 Overview of Key Vendors 94
10.2 New Product Launch, Partnership, Investment, and M&A 97
10.3 Company Profiles 98
Abbvie, Inc. 98
Acorda Therapeutics Inc. 100
Bayer AG 101
Biogen Inc. 102
Bristol-Myers Squibb Company 103
F. Hoffmann-La Roche Ltd. 104
Merck KgaA 105
Mylan NV 106
Novartis AG 107
Pfizer Inc. 108
Sanofi SA 109
Teva Pharmaceutical Industries Ltd. 110
RELATED REPORTS 111